BUSINESS
Fertiliser and agrochemical companies face multiple headwinds in FY22
Crop sowing numbers show a normal picture. But the monsoon's uneven spread has hurt sales of agrochemicals while supply constraints are weighing on fertiliser volumes
BUSINESS
Moneycontrol Pro Panorama | What can keep the recovery on course?
In today’s edition of Moneycontrol Pro Panorama: Taking guard on festive pitch, the bond rally, account aggregator ripple effect, Xi’s hallmarks, Coforge, Clean Science and Technology and more
BUSINESS
Revival in engineering services spend puts L&T Tech, Tata Elxsi firmly on growth path
L&T Technology Services' FY25 revenue target implies an average annual growth of 19 percent between FY21-25. That's good news for Tata Elxsi, too
BUSINESS
Crossword sale will reduce costs, but bigger battle awaits Shoppers Stop
Crossword lost money last fiscal and Shoppers Stop has lowered the value of its investment in the unit
BUSINESS
NCR focus to yield good dividends for Max Healthcare
Shares of Max Healthcare gained 15 percent this week after the company said it has acquired the rights to develop and operate a 500-bed hospital at Saket, South Delhi
BUSINESS
Moneycontrol Pro Panorama | Spurt in electricity prices: no easy solutions
In today’s edition of Moneycontrol Pro Panorama: Economic recovery tracker, June quarter GDP, COVID-19 vaccination, rise in electricity prices, Page Industries, Jyothy Labs and more
BUSINESS
India on the right side of gas cycle, but has to do more to avoid supply shocks
Domestic natural gas production grew for the fifth consecutive month, rising about 18 percent in July
BUSINESS
IT companies' outlook brightens on rising demand for cloud services
Global technology companies have reported robust financial performance and many of them have raised their annual revenue outlook, indicating a strong demand environment
BUSINESS
Aurobindo Pharma’s Cronus rethink is positive, but it needs to do more
Aurobindo Pharma terminated an agreement to acquire a majority stake in Cronus Pharma after the proposal stoked capital allocation concerns
BUSINESS
Moneycontrol Pro Panorama | Equity markets get a reality check
In today’s edition of Moneycontrol Pro Panorama: US Fed taper talk, commodity prices, herd immunity tracker, HDFC Bank, SpiceJet, RoDTEP rates and more
BUSINESS
Healthcare | Hospital stocks trump Big Pharma in growth and outlook
Three of the five large drug companies reported weak earnings. But large hospital chains did well and expect business to return to near normal levels
BUSINESS
Moneycontrol Pro Panorama| Recovery gains traction, but valuations are stiff
In today’s edition of Moneycontrol Pro Panorama: Economy’s uneven progress, how Afghan economy fared under the US, new COVID wave looms, housing revival, Burger King India, Petronet LNG, spectre of lockdown in Israel and more
BUSINESS
M&M gets a shot at utility vehicle market share repair
The recently launched XUV700 is competitively priced and has the potential to gain market share in the mid-sized SUV segment
BUSINESS
Capital Goods | Steady orders, enquiries drive positive outlook for companies
While order inflows gathered pace at Siemens, bookings rose for the second consecutive quarter at Thermax
BUSINESS
Interview | We will do better than industry returns in green energy, says Prashant Jain, CEO of JSW Energy
JSW Energy aims to increase the share of renewable energy capacity to 70 per cent by FY25. The company is collaborating with an Australian firm to explore opportunities in green hydrogen production
BUSINESS
Soda ash cycle turns for Tata Chemicals, but the wait for battery business plan is on
Soda ash volumes for Tata Chemicals grew for the second consecutive quarter and prices in the spot market are rising
BUSINESS
Moneycontrol Pro Panorama | RBI gives priority to growth but inflationary pressures stoke concerns
In today’s edition of Moneycontrol Pro Panorama: RBI Monetary Policy, reduction in global food prices, Herd Immunity Tracker, Nykaa IPO, Cipla, Godrej Consumer Products earnings and more
BUSINESS
Aditya Puri’s induction adds heft to Solara Pharma's growth plans
The company whose revenue grew at an average annual pace of 16.6 percent in the three years to FY21 aims to accelerate the growth rate to 25 percent in FY21-25.
BUSINESS
Cement companies sight swift demand recovery
Contrary to fears, rural demand has recovered well after the second wave. Housing and infrastructure projects are expected to drive demand too. However, a severe third wave can pose a risk.
BUSINESS
Moneycontrol Pro Panorama | It’s raining public offers and investors are spoilt for choice
In today’s edition of Moneycontrol Pro Panorama: IPOs’ gale force, the capex juggernaut moves, recovery stutters, right call for Airtel, Policybazaar’s moat, the growing muscle of quants, and more
BUSINESS
Govt’s infra focus can aid capex recovery, fiscal support key
An analysis of the order announcements by industrial firms and contract awarding agencies by Investec Capital Services shows healthy ordering activity in the June quarter
BUSINESS
Cognizant results indicate strong demand for IT services, fulfilment key challenge
Cognizant has reported notable growth in order bookings and raised the guidance for calendar year 2021
BUSINESS
V-Mart's South India foray needs careful manoeuvring
The acquisition makes V-Mart a pan-India value fashion retailer by giving it a presence in South India
BUSINESS
Record order wins provide fresh impetus to Mphasis’ growth
Order inflows in the June quarter are equivalent to 45 percent of the total deal wins in FY21. The strong order wins will help Mphasis overcome revenue deceleration in one large account
